DA Davidson reaffirms buy rating on Nature’s Sunshine stock

Published 03/06/2025, 13:52
DA Davidson reaffirms buy rating on Nature’s Sunshine stock

On Tuesday, DA Davidson analysts maintained their Buy rating on Nature’s Sunshine Products stock, despite a recent 9% decline in share price. The firm kept its price target at $19.00, expressing confidence in the company’s future prospects. According to InvestingPro analysis, the stock appears undervalued at current levels, with analyst targets ranging from $19 to $21.

Nature’s Sunshine Products, trading under (NASDAQ:NATR), faced a sell-off following the announcement that CEO Terrence Moorehead will step down. Despite this leadership change, DA Davidson analysts believe the company is well-positioned to handle the transition smoothly, supported by impressive gross profit margins of 71.7% and a strong current ratio of 2.4x.

The analysts noted that Nature’s Sunshine is cycling out of challenging comparisons in its North American operations. They observed signs of improvement that could positively impact both estimates and investor sentiment.

Additionally, the company’s proactive management strategies, a clean balance sheet, and a recent $25 million share repurchase program are seen as factors that could enhance shareholder value. The analysts emphasized that Nature’s Sunshine remains on solid ground as it prepares for a leadership transition.

In other recent news, Nature’s Sunshine Products reported impressive first-quarter 2025 earnings, surpassing market expectations. The company achieved an earnings per share (EPS) of $0.25, significantly higher than the forecasted $0.17, and exceeded revenue projections with $113.2 million against the anticipated $109.42 million. This strong performance was driven by notable growth in digital sales and robust results in Asia Pacific and Europe. Additionally, Nature’s Sunshine reaffirmed its full-year 2025 financial outlook, maintaining previous guidance for net sales and adjusted EBITDA. The company also announced a $25 million share repurchase program, indicating confidence in its future prospects.

In leadership developments, Nature’s Sunshine disclosed that CEO Terrence Moorehead will step down upon the appointment of a successor, with a search for a new leader already underway. DA Davidson resumed coverage on the company, assigning a Buy rating and adjusting the price target to $19, citing the company’s strong financial position and recent performance. The firm noted Nature’s Sunshine’s sequential improvement across regions and visible growth opportunities. These developments reflect the company’s strategic focus on digital transformation and operational efficiency, contributing to its positive outlook.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.